Elixinol Wellness Limited
ELLXF
$0.01
$0.0092.50%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -3.29% | -6.24% | 9.70% | 7.65% | 69.98% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -3.57% | -6.52% | 10.03% | 7.97% | 69.98% |
| Cost of Revenue | -6.92% | -9.76% | 9.93% | 7.88% | 66.64% |
| Gross Profit | 2.16% | -0.97% | 10.21% | 8.15% | 76.06% |
| SG&A Expenses | 8.82% | 5.49% | 11.37% | 9.28% | 0.28% |
| Depreciation & Amortization | -28.57% | -30.79% | -7.46% | -9.23% | 51.61% |
| Other Operating Expenses | -168.48% | -166.40% | 156.03% | 151.23% | 280.49% |
| Total Operating Expenses | -7.55% | -10.38% | 11.70% | 9.61% | 37.71% |
| Operating Income | 21.47% | 23.87% | -15.86% | -13.70% | 17.28% |
| Income Before Tax | -15.93% | -12.39% | -9.14% | -7.09% | 37.82% |
| Income Tax Expenses | 84.99% | 85.45% | -- | -- | -390,000.00% |
| Earnings from Continuing Operations | -334.46% | -327.31% | -9.10% | -7.05% | 125.15% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -334.46% | -327.31% | -9.10% | -7.05% | 125.15% |
| EBIT | 21.47% | 23.87% | -15.86% | -13.70% | 17.28% |
| EBITDA | 33.11% | 35.15% | -27.52% | -25.12% | 14.89% |
| EPS Basic | -250.00% | -242.11% | 38.36% | 39.73% | 109.89% |
| Normalized Basic EPS | 40.74% | 42.86% | 28.89% | 31.11% | 65.82% |
| EPS Diluted | -250.00% | -242.11% | 38.36% | 39.73% | 109.84% |
| Normalized Diluted EPS | 40.74% | 42.86% | 28.89% | 31.11% | 65.82% |
| Average Basic Shares Outstanding | 57.44% | 57.44% | 78.10% | 78.10% | 151.00% |
| Average Diluted Shares Outstanding | 57.44% | 57.44% | 78.10% | 78.10% | 151.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |